{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T06:46:44Z","timestamp":1773211604140,"version":"3.50.1"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T00:00:00Z","timestamp":1457481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150745","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T18:47:27Z","timestamp":1457549247000},"page":"e0150745","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":29,"title":["The Dose-Dependent Organ-Specific Effects of a Dipeptidyl Peptidase-4 Inhibitor on Cardiovascular Complications in a Model of Type 2 Diabetes"],"prefix":"10.1371","volume":"11","author":[{"given":"Ju-Young","family":"Moon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jong Shin","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung-Woo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arah","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dong Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang-Gyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Se-Yeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hye","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Jig","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xian Wu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,3,9]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"JJ Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"BM Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"WB White","year":"2013","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"18123","DOI":"10.1073\/pnas.0509145102","article-title":"Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia","volume":"102","author":"CM Wolf","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2337\/db09-0955","article-title":"Genetic deletion or pharmacological inhibition of dipeptidyl peptidase-4 improves cardiovascular outcomes after myocardial infarction in mice","volume":"59","author":"M Sauve","year":"2010","journal-title":"Diabetes"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1161\/CIRCHEARTFAILURE.108.810887","article-title":"GLP-1 therapy: beyond glucose control","volume":"1","author":"DJ Hausenloy","year":"2008","journal-title":"Circ Heart Fail"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/ATVBAHA.110.222653","article-title":"Preventive effects of exenatide on endothelial dysfunction induced by ischemia-reperfusion injury via KATP channels","volume":"32","author":"SJ Ha","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1161\/ATVBAHA.113.301586","article-title":"Cardioprotective effects of exenatide in patients with ST-segment-elevation myocardial infarction undergoing primary percutaneous coronary intervention: results of exenatide myocardial protection in revascularization study","volume":"33","author":"JS Woo","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/01.RES.87.12.1123","article-title":"Myocardial cell death in human diabetes","volume":"87","author":"A Frustaci","year":"2000","journal-title":"Circ Res"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S1054-8807(01)00116-8","article-title":"Experimental diabetes and left ventricular hypertrophy: effects of beta-receptor blockade","volume":"11","author":"D Grimm","year":"2002","journal-title":"Cardiovasc Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"H2079","DOI":"10.1152\/ajpheart.00092.2008","article-title":"Ser9 phosphorylation of mitochondrial GSK-3beta is a primary mechanism of cardiomyocyte protection by erythropoietin against oxidant-induced apoptosis","volume":"295","author":"K Ohori","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1172\/JCI19906","article-title":"Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore","volume":"113","author":"M Juhaszova","year":"2004","journal-title":"J Clin Invest"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIRCULATIONAHA.107.755066","article-title":"Inhibition of GSK3beta by postconditioning is required to prevent opening of the mitochondrial permeability transition pore during reperfusion","volume":"117","author":"L Gomez","year":"2008","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"162092","DOI":"10.1155\/2011\/162092","article-title":"Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat)","volume":"2011","author":"C Mega","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1124\/jpet.111.186866","article-title":"Dipeptidyl peptidase IV inhibitor attenuates kidney injury in streptozotocin-induced diabetic rats","volume":"340","author":"WJ Liu","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"538737","DOI":"10.1155\/2014\/538737","article-title":"Sitagliptin prevents inflammation and apoptotic cell death in the kidney of type 2 diabetic animals","volume":"2014","author":"C Marques","year":"2014","journal-title":"Mediators Inflamm"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1042\/CS20120167","article-title":"Role of GLP-1 and DPP-4 in diabetic nephropathy and cardiovascular disease","volume":"124","author":"U Panchapakesan","year":"2013","journal-title":"Clin Sci (Lond)"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1097\/HJH.0000000000000328","article-title":"Blood pressure and glucose independent renoprotective effects of dipeptidyl peptidase-4 inhibition in a mouse model of type-2 diabetic nephropathy","volume":"32","author":"Y Sharkovska","year":"2014","journal-title":"J Hypertens"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.2337\/db13-1029","article-title":"Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen","volume":"63","author":"K Kanasaki","year":"2014","journal-title":"Diabetes"},{"key":"ref20","first-page":"1","article-title":"DPP4 Inhibition in Human Kidney Proximal Tubular Cells -Renoprotection in Diabetic Nephropathy?","volume":"S9","author":"Usha Panchapakesan","year":"2013","journal-title":"J Diabetes Metab"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150745","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T07:46:38Z","timestamp":1589010398000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150745"}},"subtitle":[],"editor":[{"given":"Andrea","family":"Caporali","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,3,9]]},"references-count":20,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150745","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,9]]}}}